Most cited papers from Holy Cross University

Holy Cross University

What are the most cited papers from Holy Cross University?

The most cited paper from Holy Cross University is "Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy" (Tomasz Byrski, Jacek Gronwald, Tomasz Huzarski et al., 2009), with 516 citations. Next come "Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy" (508) and "Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice" (248).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 55 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy Tomasz Byrski, Jacek Gronwald, Tomasz Huzarski et al. · Journal of Clinical Oncology Open access	15 Dec 2009	516
2	Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Krzysztof Bujko, Marek P. Nowacki, Anna Maria Nasierowska-Guttmejer et al. · Radiotherapy and Oncology	14 Feb 2004	508
3	Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice Vinidh Paleri, Richard G. Wight, Carl E. Silver et al. · Oral Oncology Open access	18 Sep 2010	248
4	Estrogen Receptor Signaling in Breast Cancer Paulina Anna Miziak, Marzena Teresa Baran, Ewa Błaszczak et al. · Cancers Open access	23 Sep 2023	201
5	European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer Maaike H.M. Oonk, François Planchamp, Peter Baldwin et al. · International Journal of Gynecological Cancer Open access	8 Apr 2017	198
6	A high proportion of founder BRCA1 mutations in Polish breast cancer families Bohdan Górski et al. · International Journal of Cancer Open access	15 Mar 2004	196
7	Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy Ewelina Piktel, Katarzyna Niemirowicz, Marzena Wątek et al. · Journal of Nanobiotechnology Open access	26 May 2016	173
8	Metallic Nanosystems in the Development of Antimicrobial Strategies with High Antimicrobial Activity and High Biocompatibility Karol Skłodowski, Sylwia Joanna Chmielewska-Deptuła, Ewelina Piktel et al. · International Journal of Molecular Sciences Open access	20 Jan 2023	170
9	Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial Lucyna Pietrzak, Krzysztof Bujko, Marek P. Nowacki et al. · Radiotherapy and Oncology	11 Aug 2007	162
10	The effect of chemical modification on the physico-chemical characteristics of halloysite: FTIR, XRF, and XRD studies Beata Szczepanik, P. M. Słomkiewicz, Magdalena Garnuszek et al. · Journal of Molecular Structure	9 Dec 2014	161
11	Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid tumors Artur Kowalik, Magdalena Kowalewska, Stanisław S. Góźdź · Translational research Open access	26 Apr 2017	153
12	The effect of purine on the corrosion of copper in chloride solutions Mieczysław Scendo · Corrosion Science	23 Sep 2006	145
13	Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers Tomasz Byrski, Jacek Gronwald, Tomasz Huzarski et al. · Breast Cancer Research and Treatment	9 May 2007	139
14	CHEK 2 mutations and the risk of papillary thyroid cancer Monika Siołek, Cezary Cybulski, Danuta Gąsior‐Perczak et al. · International Journal of Cancer Open access	12 Jan 2015	127
15	Telomeres and telomerase in oncogenesis (Review) Tomasz Trybek, Artur Kowalik, Stanisław S. Góźdź et al. · Oncology Letters Open access	21 May 2020	123
16	Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma Anna Sowa‐Staszczak, Dorota Pach, Renata Mikołajczak et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access	6 Dec 2012	119
17	Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial David Cibula et al. · European Journal of Cancer Open access	31 Jul 2020	118
18	Proposal for a rational classification of neck dissections Alfio Ferlito et al. · Head & Neck Open access	17 Nov 2010	116
19	The Role of Cathelicidin LL-37 in Cancer Development Ewelina Piktel, Katarzyna Niemirowicz, Urszula Wnorowska et al. · Archivum Immunologiae et Therapiae Experimentalis Open access	22 Sep 2015	115
20	Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5 Luigino Dal Maso et al. · European Journal of Cancer Open access189 authors	11 Apr 2017	105
21	Copper, Zinc, and Selenium in Whole Blood and Thyroid Tissue of People with Various Thyroid Diseases Marek Kucharzewski, J. Braziewicz, U. Majewska et al. · Biological Trace Element Research	2003	103
22	Inhibition of copper corrosion in sodium nitrate solutions with nontoxic inhibitors Mieczysław Scendo · Corrosion Science	12 Apr 2008	94
23	Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy Antoni Domagała, Klaudyna Fidyt, Małgorzata Bobrowicz et al. · International Journal of Molecular Sciences Open access	Aug 2018	92
24	Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer Kinga Hińcza, Artur Kowalik, Aldona Kowalska · Genes Open access	26 Jun 2019	86
25	KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin1 1The opinions and assertions contained herein are the expressed views of the authors and are not to be construed as official or reflecting the views of the Departments of the Army or Defense. Jerzy P. Lasota, Janusz Kopczyński, Maarit Sarlomo‐Rikala et al. · Human Pathology Open access	Dec 2003	86
26	Hereditary ovarian cancer in Poland Janusz Menkiszak et al. · International Journal of Cancer	6 Aug 2003	86
27	Surface Enhanced Raman Spectroscopy for DNA Biosensors—How Far Are We? Edyta Pyrak, Jan Krajczewski, Artur Kowalik et al. · Molecules Open access	4 Dec 2019	85
28	CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer Dominika Bębnowska, Ewelina Grywalska, Paulina Niedźwiedzka‐Rystwej et al. · Journal of Clinical Medicine Open access	17 Jun 2020	84
29	A common variant of CDKN2A (p16) predisposes to breast cancer: Table 1 Tadeusz Dębniak et al. · Journal of Medical Genetics Open access	6 May 2005	83
30	Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites Bonita Durnaś, Urszula Wnorowska, Katarzyna Pogoda et al. · PLoS ONE Open access	17 Jun 2016	82
31	Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics Katarzyna Niemirowicz, Bonita Durnaś, Grażyna Tokajuk et al. · Nanomedicine Nanotechnology Biology and Medicine	26 Jul 2016	81
32	Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells Katarzyna Niemirowicz, Izabela Prokop, Agnieszka Zofia Wilczewska et al. · International Journal of Nanomedicine Open access	Jun 2015	80
33	Inhibitive action of the purine and adenine for copper corrosion in sulphate solutions Mieczysław Scendo · Corrosion Science	6 Mar 2007	77
34	Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome Zoran Erlic, Michael Marcus Hoffmann, Maren Sullivan et al. · The Journal of Clinical Endocrinology & Metabolism Open access	12 Nov 2009	76
35	Corrosion inhibition of copper by purine or adenine in sulphate solutions Mieczysław Scendo · Corrosion Science	19 May 2007	75
36	ROS-Mediated Apoptosis and Autophagy in Ovarian Cancer Cells Treated with Peanut-Shaped Gold Nanoparticles Ewelina Piktel, Ilona Ościłowska, Łukasz Suprewicz et al. · International Journal of Nanomedicine Open access	Mar 2021	74
37	Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer Ewelina Grywalska, Marcin Pasiarski, Stanisław S. Góźdź et al. · OncoTargets and Therapy Open access	Oct 2018	74
38	Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins Katarzyna Niemirowicz, Ewelina Piktel, Agnieszka Zofia Wilczewska et al. · International Journal of Nanomedicine Open access	Oct 2016	72
39	Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients – Preliminary Report Marcin Pasiarski, Jacek Roliński, Ewelina Grywalska et al. · PLoS ONE Open access	15 Dec 2014	72
40	Concentration of Selenium in the Whole Blood and the Thyroid Tissue of Patients with Various Thyroid Diseases Marek Kucharzewski, J. Braziewicz, U. Majewska et al. · Biological Trace Element Research	2002	69
41	The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity Joanna Domagała, Mieszko Lachota, Marta Kłopotowska et al. · Cancers Open access	27 Nov 2020	65
42	Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union Florian Al. Nicula, Ahti Anttila, Luciana Neamţiu et al. · European Journal of Cancer	20 Aug 2009	65
43	Potassium ethyl xanthate as corrosion inhibitor for copper in acidic chloride solutions Mieczysław Scendo · Corrosion Science	3 Nov 2004	65
44	Pseudomonas aeruginosa Infections in Cancer Patients Paulina Paprocka, Bonita Durnaś, Angelika Mańkowska et al. · Pathogens Open access	12 Jun 2022	63
45	The assessment of the usability of selected instrumental techniques for the elemental analysis of biomedical samples Karolina Planeta, Aldona Kubala‐Kukuś, Agnieszka Dróźdż et al. · Scientific Reports Open access	12 Feb 2021	61
46	Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement Denis Querleu, David Cibula, Nicole Concin et al. · International Journal of Gynecological Cancer Open access	28 Nov 2019	61
47	Corrosion inhibition of copper by potassium ethyl xanthate in acidic chloride solutions Mieczysław Scendo · Corrosion Science	25 Feb 2005	61
48	Selective cytotoxicity and antifungal properties of copper(II) and cobalt(II) complexes with imidazole-4-acetate anion or 1-allylimidazole Katarzyna Gałczyńska, Karol Ciepluch, Łukasz Madej et al. · Scientific Reports Open access	5 Jul 2019	60
49	Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets Sebastian Zięba, Artur Kowalik, Kamil Zalewski et al. · Gynecologic Oncology Open access	3 Jul 2018	60
50	Trace element concentration distributions in breast, lung and colon tissues U. Majewska, Dariusz Banaś, J. Braziewicz et al. · Physics in Medicine and Biology	4 Jun 2007	59

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.